Industry Developments Resource Center

• › Articles (164)
• › White Papers (59)
• › News (856)
• › Products (7)

Pfizer Gets “Punked”: A Musical Rant Against Downsizing
PharmaManufacturing.com
Pfizer’s downsizing in Ann Arbor and the state of the economy have some punk rockers raging against the Big Pharma machine.

Pfizer Downsizing Opens New Doors — 16 CROs Spawned
PharmaManufacturing.com
The company’s loss may, in the end, be industry’s gain as entrepreneurs start their own ventures.

Team of the Year (Small Company): Organogenesis' Apligraf Manufacturing Team
The Apligraf manufacturing team at Organogenesis is Pharmaceutical Manufacturing's Team of the Year among teams at small manufacturers.

Our Team of the Year: Wyeth CH Supplier Quality Excellence Team
PharmaManufacturing.com
Wyeth Consumer Healthcare’s Supplier Quality Excellence team has been selected as “Team of the Year” by Pharmaceutical Manufacturing magazine.

More Articles »

White Papers: In Depth Research

Enhancing Protein Analysis with Mass Spectrometry in Pharmaceutical Development of Biotherapeutics
Author: Bruker Daltonics
Posted: 09/11/2008
As the desire to bring more commercially successful biological therapeutics to market grows, the need to bring easier and more sophisticated analyses of these complex molecules also increases. In contrast to small molecules, many of the development, production, and QC issues surrounding biotherapeutics can be quite a bit more complicated due to the inherent complexity of the molecules. To help facilitate the development of biotherapeutics, Mass Spectrometry can be used as a powerful tool for all types of product analyses ranging from protein and peptide fingerprinting and sequencing, impurity and degradant identification, to analysis of post-translational modifications.

Pharma 2020: Virtual R&D
Author: PriceWaterhouse Coopers
Posted: 07/11/2008
The second paper in the PwC Pharma 2020 series, explores how pharma companies could dramatically improve the R&D productivity. It contends that by 2020 the R&D process may be shortened by two-thirds, success rates may dramatically increase, and clinical trial costs could be cut substantially. New computer based technologies will create a greater understanding of the biology of disease and the evolution of "Virtual man"; to enable researchers to predict the effects of new drug candidates before they enter human beings. Along with changes underway in the regulatory and socio-political environment, this will enable Pharma to overcome one of the most fundamental issues it needs to resolve over the next decade.

Risk Management in Next Generation Outsourcing
Author: Hunton & Williams and Marsh
Posted: 03/11/2008
In the white paper, law firm Hunton & Williams and leading insurance broker Marsh examine how new outsourcing models have resulted in new areas of risk and a more complex contractual and commercial structure being required.

Implementing Single-Use Systems in Existing Facilities
Author: Kim L. Nelson, Ph.D., CRB Consulting Engineers
Posted: 03/10/2008
This paper by CRB Consulting Engineers will focus on implementing disposable process equipment in existing facilities which also utilize stainless equipment, highlighting the logistics and design issues that must be addressed to ensure success in both the initial installation and ongoing operations.

More White Papers »